Request Demo
Last update 05 Jun 2026
NTQ-1062
Last update 05 Jun 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms NTQ1062 |
Target |
Action inhibitors |
Mechanism AKT gene inhibitors |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC25H31ClN6O2 |
InChIKeyRXNPEQZHMGFNAY-GEALJGNFSA-N |
CAS Registry2459489-66-6 |
Related
5
Clinical Trials associated with NTQ-1062NCT07393321
A Randomized, Double-blind, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of NTQ1062 in Combination With Fulvestrant Versus Placebo Plus Fulvestrant in Patients With Locally Advanced (Unresectable) or Metastatic HR+/HER2- Breast Cancer Who Relapsed or Progressed During or After Endocrine Therapy.
CTR20253126
NTQ1062片健康志愿者食物影响研究
[Translation] Study on the food effect of NTQ1062 tablets in healthy volunteers
ChiCTR2600119802
Study on the Effect of Food on Healthy Volunteers of NTQ1062 Tablets
100 Clinical Results associated with NTQ-1062
Login to view more data
100 Translational Medicine associated with NTQ-1062
Login to view more data
100 Patents (Medical) associated with NTQ-1062
Login to view more data
100 Deals associated with NTQ-1062
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Unresectable Breast Carcinoma | Phase 3 | - | 10 Feb 2026 | |
| Metastatic human epidermal growth factor 2 positive carcinoma of breast | Phase 3 | - | 10 Feb 2026 | |
| Hormone receptor positive HER2 negative breast cancer | Phase 3 | China | 30 Jan 2026 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 13 Sep 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free